Treats Attention Deficit Hyperactivity Disorders (ADHD) and Narcolepsy. ANDA 90710, held by Sun Pharmaceutical Industries. Methylphenidate Hydrochloride.
As of Nov 21, 2026, ANDA 90710 (Methylphenidate Hydrochloride), held by Sun Pharmaceutical Industries, was first approved by FDA on Mar 15, 2012, with 8 approved supplements and 0 published complete response letters.
Methylphenidate hydrochloride tablets are indicated for the treatment of: Attention Deficit Hyperactivity Disorders (ADHD) in pediatric patients 6 years and older and adults Narcolepsy Methylphenidate hydrochloride tablets are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorders (ADHD) and Narcolepsy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 15, 2012 | Original application | Approved | None posted |
| Methylphenidate Hydrochloride5MG · tablet;oral | Methylphenidate Hydrochloride | Rx |
| Methylphenidate Hydrochloride10MG · tablet;oral | Methylphenidate Hydrochloride | Rx |
| Methylphenidate Hydrochloride20MG · tablet;oral | Methylphenidate Hydrochloride | Rx |
| Feb 28, 2024 | Supplement 25Labeling · Standard review | Approved | None posted |
| Feb 28, 2024 | Supplement 28Labeling · Standard review | Approved | None posted |
| Jan 8, 2020 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jan 8, 2020 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jan 8, 2020 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jan 8, 2020 | Supplement 19Labeling · Standard review | Approved | None posted |
| Jan 8, 2020 | Supplement 23Labeling · Standard review | Approved | None posted |
| Jan 16, 2014 | Supplement 7Labeling · Standard review | Approved | None posted |
| Mar 15, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters